1) Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol 1999;20(4):250-78.
2) 日本手術医学会.手術医療の実践ガイドライン.第7章 手術と感染防止.日手術医会誌2008;29:S47-59.
3) Iorio ML, Shuck J, Attinger CE. Wound healing in the upper and lower extremities:a systematic review on the use of acellular dermal matrices. Plast Reconstr Surg 2012;130 (5 Suppl 2):S 232-41.
4) Krug E, Berg L, Lee C, et al;International Expert Panel on Negative Pressure Wound Therapy. Evidence-based recommendations for the use of Negative Pressure Wound Therapy in traumatic wounds and reconstructive surgery:steps towards an international consensus. Injury 2011;42(Suppl 1):S1-12.
5) Kim JH, Lee DH. Are high-risk patient and revision arthroplasty effective indications for closed-incisional negative-pressure wound therapy after total hip or knee arthroplasty? A systematic review and meta-analysis. Int Wound J 2020;17(5):1310-22.
6) Murphy C, Atkin L, Swanson T, et al. Defying hard-to-heal wounds with an early antibiofilm intervention strategy:wound hygiene. J Wound Care 2020;29(Sup3b):S1-S26.
7) 国立医薬品食品衛生研究所医療機器部.(別紙2)難治性創傷治療機器の臨床評価.https://dmd.nihs.go.jp/jisedai/tsuuchi/index.html(2021年10月15日アクセス)
8) Matsuda T, Ohura N, Mineta K, et al. Guidance Development Committee for Clinical Trial Protocols for Chronic Wound Treatment Medical Devices. Hard-to-heal wound treatment medical devices:clinical trial protocol in Japan. J Wound Care 2021;30(8):666-76.
9) Sheehan P, Jones P, Giurini JM, et al. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Plast Reconstr Surg 2006;117(7 Suppl):239S-44S.
10) Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation:a systematic approach to wound management. Wound Repair Regen 2003;11(Suppl 1):S1-28.